[{"arm_notes": "", "treatment_id": null, "treatment_name": "The 1600 mg/ day of Favipiravir tablets or solution were assigned to a randomized family cluster (1: 1) for 7 days. Dose adjustment to obesity household contacts is 2000 mg/day.;Standard protocol and treatment in duration 14 days;Active Comparator Drug;No Intervention No treatment;Favipiravir tablets or solution post exposure prophylaxis group;No post exposure prophylaxis group", "treatment_type": "TODO", "pharmacological_treatment": "TODO"}]

[{"arm_notes": "", "treatment_id": 504, "treatment_name": "Favipiravir", "treatment_type": "Antivirals", "pharmacological_treatment": "Pharmacological treatment"}, {"arm_notes": "", "treatment_id": 2188, "treatment_name": "Standard of care", "treatment_type": "Standard of care", "pharmacological_treatment": "Standard of care"}]